Clinical Trial Update: Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluated whether suppressive therapy for genital herpes affects HIV shedding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes
• HIV Infection

Drugs mentioned

• ACYCLOVIR (Acyclovir)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Herpes Genitalis, HIV Infection | Phase 2 | Status: COMPLETED